Cervical cancer is the fourth most common malignancy in females worldwide, and a leading
cause of death in the United Kingdom (UK). The human papillomavirus (HPV) is the …

Introduction Human papillomavirus (HPV) self-sampling test kits may increase screening for
and early detection of cervical cancer and reduce its burden globally. To inform WHO self …

Objective To evaluate the diagnostic accuracy of high-risk human papillomavirus (hrHPV)
assays on self samples and the efficacy of self sampling strategies to reach underscreened …

Background Human papillomavirus (HPV) testing on self-samples represents a great
opportunity to increase cervical cancer screening uptake among under-screened women …

Introduction Population coverage for cervical cancer screening is an important determinant
explaining differences in the incidence of cervical cancer between countries. Offering …

Background Human papillomavirus (HPV) testing on self-collected samples is a potential
alternative to HPV testing on clinician-collected samples, but non-inferiority of its clinical …

Background Control of cervical cancer in developing countries has been hampered by a
failure to achieve high screening uptake. HPV DNA self-collection could increase screening …

The persisting burden of cervical cancer in underserved populations and low-resource
regions worldwide, worsened by the onset of the COVID-19 pandemic, requires proactive …

Objective To provide a focused critical review of the literature on the acceptability, feasibility,
and uptake of human papillomavirus (HPV) self-sampling among hard-to-reach women …

This review elaborates on the accuracy and feasibility of human papillomavirus (HPV) self‐
sampling, ie, offering self‐sampling of (cervico‐) vaginal cell material by women themselves …